Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeEXECUTIVESJennifer Martin and Dan Rogers Added to the Omnia Medical Team: Martin...

Jennifer Martin and Dan Rogers Added to the Omnia Medical Team: Martin to Lead the Interventional Pain Therapies Division Alongside Thomas Batton and Dan Rogers

December 30, 2020

Jennifer Martin and Dan Rogers have been added to the Omnia Medical team.

Jennifer Martin will lead Omnia Medical’s Interventional Pain Therapies Division alongside Thomas Batton and Dan Rogers.

The new team members will be crucial in the expansion of Omnia Medical and the launch of a new division created for the sole focus of helping Pain Management Specialists provide leading-edge care to patients with debilitating pain due to Sacroiliac (SI) joint dysfunction.

Jennifer Martin, President of the new Interventional Pain Therapies division, brings over 15 years of experience in product training and market development. Most recently she served as Senior Director of Customer Engagement at Boston Scientific. Prior to her time at Boston Scientific, she served as CEO of Next Level Interactive, Sr. Director of Field and Physician Development at St. Jude Medical, and Vice President of Global Sales Training at KCI Medical.

Ms. Martin will be working closely with Dan Rogers as he joins Omnia Medical as the Vice President of Sales for the new division. He most recently served as Regional Sales Director at Boston Scientific and Vertiflex. With more than a decade of experience, Dan Rogers will join Thomas Batton and Sean Herd in working closely with Ms. Martin to grow and further advance technologies within the Interventional Pain Therapies division.

“I am incredibly excited to join Omnia Medical. The Company has a unique opportunity to accelerate an already impressive growth trajectory and become the posterior SI joint fusion system of choice for interventional pain management physicians and spine surgeons. I look forward to working with our Omnia Medical team and applying my experience and deep understanding of market development and growth for medical device companies.” – Jennifer Martin, President of Omnia Medical’s Interventional Pain Therapies division.

This new division will provide a strong collaboration between Spine Surgeons and Pain Management Specialists when diagnosing accurate patient pathology as spine related or SI joint dysfunction. This collaboration will further provide an opportunity for Pain Management Specialists to integrate SI joint fusion technologies in their treatment algorithm for patients.

The launch of the new division comes at a critical time when providers are increasingly focused on delivering a more comprehensive range of therapies. Omnia Medical is combining its research and development expertise with manufacturing experience to provide minimally invasive solutions tailored specifically to Pain Management Specialists.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy